Cargando…

Positive Impact of a Pilot Pharmacist-Run Diabetes Pharmacotherapy Clinic in Solid-Organ Transplant Recipients

PURPOSE. Post-transplant diabetes mellitus (PTDM) can lead to significant morbidity and cardiovascular death with a functioning graft. A paucity of literature exists regarding glycemic control in solid-organ transplant (SOT) recipients, including pharmacist management of PTDM. This study aimed to as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Newland, David M., Edwards, Angelina R., Hall, Reed C., Maxwell, Pamela R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2018
Materias:	Feature Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951228/ https://www.ncbi.nlm.nih.gov/pubmed/29773937 http://dx.doi.org/10.2337/ds17-0029

Ejemplares similares

Pharmacotherapy for Depression and Anxiety in the Primary Care Setting
por: Parish, Abby Luck, et al.
Publicado: (2023)

The pharmacist’s role in SARS-CoV-2 diagnostic testing
por: Goode, Jean-Venable R., et al.
Publicado: (2020)

Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
por: Page, Timothy F., et al.
Publicado: (2008)

Infections in Solid-Organ Transplant Recipients
por: Singh, Nina, et al.
Publicado: (2015)

Overactive bladder syndrome pharmacotherapy: future treatment options
por: Wróbel, Andrzej
Publicado: (2015)

Antitumor pharmacotherapy of colorectal cancer in kidney transplant recipients
por: Fu, Yuanyuan, et al.
Publicado: (2019)

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
por: Snowden, John A., et al.
Publicado: (2022)

Antivirals for COVID-19 in Solid Organ Transplant Recipients
por: Laracy, Justin C., et al.
Publicado: (2020)

Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions
por: Grabenstein, John D.
Publicado: (2022)

Human Epigenome Project—Up and Running
por: Bradbury, Jane
Publicado: (2003)

Pneumocystis Pneumonia in Solid-Organ Transplant Recipients
por: Iriart, Xavier, et al.
Publicado: (2015)

Histoplasmosis and Blastomycosis in Solid Organ Transplant Recipients
por: Kauffman, Carol A., et al.
Publicado: (2015)

Infections in pediatric solid organ transplant recipients
por: Fonseca-Aten, Monica, et al.
Publicado: (2006)

Primary Care of the Solid Organ Transplant Recipient
por: Ruzgar, Nensi Melissa, et al.
Publicado: (2021)

Respiratory Viruses in Solid Organ Transplant Recipients
por: Bitterman, Roni, et al.
Publicado: (2021)

Mycobacterial infections in solid organ transplant recipients
por: Rashid, Harun Ur, et al.
Publicado: (2021)

Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens
por: Edwards, B. J., et al.
Publicado: (2011)

Clinical spectrum of phaeohyphomycosis in solid organ transplant recipients
por: Tirico, Maria Claudia Carvas Passarelli, et al.
Publicado: (2016)

Good Pharmacy Practice Standardized for Community Pharmacists: The Lebanese Order of Pharmacists Initiative
por: Hallit, Souheil, et al.
Publicado: (2019)

918. Pilot Surveillance for Carbapenemase Gene-positive Organisms Among Hospitalized Solid Organ Transplant Recipients
por: Chan, June L, et al.
Publicado: (2020)

Optimizing pharmacotherapy in elderly patients: the role of pharmacists
por: Lee, Jeannie K, et al.
Publicado: (2015)

Bullous necrotizing cellulitis in kidney transplant recipient
por: Neild, G. H., et al.
Publicado: (2011)

Pharmacotherapy and the Role of Pharmacists in Rehabilitation Medicine
por: Yoshimura, Yoshihiro, et al.
Publicado: (2022)

Application of Novel Pharmacists’ Risk in Pharmacotherapy (PHARIPH) Scale for Identification of Factors Affecting the Safety of Hospital Pharmacotherapy—An Observational Pilot Study
por: Fedorowicz, Olga, et al.
Publicado: (2022)

Invasive Mold Infections in Solid Organ Transplant Recipients
por: Crabol, Yoann, et al.
Publicado: (2014)

Bacillary angiomatosis in a solid organ transplant recipient
por: Schwensen, Jakob Ferløv, et al.
Publicado: (2019)

Impact of COVID-19 in solid organ transplant recipients
por: Danziger-Isakov, Lara, et al.
Publicado: (2021)

Diagnostic Approach to Coccidioidomycosis in Solid Organ Transplant Recipients
por: Zangeneh, Tirdad T., et al.
Publicado: (2023)

Donor-derived infections in solid organ transplant recipients
por: Peghin, Maddalena, et al.
Publicado: (2023)

Risk of Rare Cancers Among Solid Organ Transplant Recipients
por: D’Arcy, Monica E, et al.
Publicado: (2020)

The role of the pharmacist in the management of kidney transplant recipients
por: Wiegel, Joshua J., et al.
Publicado: (2016)

1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients
por: Friedman, Daniel, et al.
Publicado: (2019)

Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update
por: Abad, Cybele L., et al.
Publicado: (2016)

Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

Role of pharmacist counseling in pharmacotherapy quality improvement
por: Sanii, Yalda, et al.
Publicado: (2016)

Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
por: Vergidis, Pascalis, et al.
Publicado: (2017)

The declaration of Istanbul on organ trafficking and transplant tourism
Publicado: (2008)

Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients
por: Yetmar, Zachary A, et al.
Publicado: (2021)

Invasive candidiasis serological diagnosis in solid organ transplant recipients
por: Piskorska, Katarzyna, et al.
Publicado: (2014)

Concomitant angiosarcoma and lymphoproliferative disorder in solid organ transplant recipients
por: Baer, Lea N, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_joj2ql29oirk1s2gaq0991hse7